A novel highly potent and selective 11β-hydroxysteroid dehydrogenase type 1 inhibitor, UI-1499

These results suggest that the 11β-HSD1 inhibitor, UI-1499, may serve as a novel drug candidate for the treatment of type 2 diabetes and metabolic syndrome.